Pioglitazone
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University Hospitals Cleveland Medical Center
Overview
Pioglitazone is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Pioglitazone clinical trials
Explore related
Medical disclaimer. This page summarizes research about Pioglitazone for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.